Rare diseases
Investigational molecules
Locations
Back to Greece174 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
GreecePhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
GreeceSafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
GreecePhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
GreeceA Study to Assess Safety and Efficacy of Surzetoclax Alone or with Etentamig in Adults with Relapsed or Refractory Multiple Myeloma
GreeceStudy of levofloxacin, ketorolac trometamol, and dexamethasone eye drops for preventing inflammation and infection after cataract surgery in adults
GreecePhase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments
GreecePhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
GreeceStudy of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer
GreeceWeekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature
GreeceEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
GreeceStudy of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
